Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan for Sickle Nephropathy
NCT01479439Phase 2Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Feb 2012
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of losartan in sickle cell nephropathy (SCN), sponsored by Cincinnati Children's Hospital Medical Center. Started Feb 2012; status: completed.
02
Drugs
losartan
03
Conditions
sickle cell nephropathy (SCN)
Beyond the preview
Go deeper on NCT01479439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01479439.